The Balb/c3T3 cell transformation assay (CTA) is an available in vitro system to detect the carcinogenic potential of chemicals. Currently, the European Centre for the Validation of Alternative Methods (ECVAM) is validating this test, assessing its reliability and relevance. Its endpoint is the formation of type III foci, which is, when using clone A31-1-1, a very rare event that usually does not occur at all for negative controls. The carcinogenic potential of a compound tested is assessed by comparing the number of foci in treated and untreated cells. The objective of the present work is to optimise the data analysis for this endpoint by applying the most commonly used approach by a t-test and the Fisher's exact test as an alternative approach. For this purpose selected metal compounds classified as carcinogenic (NaAs0 2, CdCI 2, cisPt), as suspected carcinogenic (C6Hs)4AsCl, CH 3HgCl), or as compounds without evidence of carcinogenic properties in humans «NH4)2PtCI6' NaV0 3 ) as well as a non-carcinogenic (AgN0 3 ) were analysed. Our evaluation revealed that the t-test approach, which assumes normality of data, is not appropriate. The results demonstrated that the statistical analysis by Fisher's exact test better reflects the data properties and greatly facilitates the interpretation of Balb/c3T3 CTA data regarding carcinogenic potential.
Cancer is the second leading cause afflicting human populations with highest death tolls. Environmental chemicals are assumed to be one of the factors implicated in carcinogenesis, though, with the exception for high-dose occupational exposure, a direct link cannot be easily established (1) (2) (3) (4) . For this reason, assumptions regarding the incidence of chemically induced cancer vary largely according to authors, the most optimistic values being 1-5 % of all cancers for the general population and 2-8 % for occupationally exposed workers (5) . Whatever the real numbers, in view of the outsize amount of chemicals in our everyday life that are lacking carcinogenicity data, alternative approaches, like those based on in vitro cell transformation assays have become an essential tool to face this gap in knowledge (6) (7) (8) (9) (10) (11) . However, such tests have never reached the stage of routine assay systems, mainly because serious attempts to assess inter-laboratory reproducibility are scarce. Despite some efforts to establish uniform protocols and test guidelines (12) (13) (14) (15) , sound formal validation efforts to assess reliability and relevance are still lacking.
Recent EU policy -the T" Amendment to the Cosmetics Directive and the EU White Paper Strategy for a Future Chemicals Policy that introduces a new system for the Registration, Evaluation and Authorisation of chemical substances (REACH) -spur developments towards validation. They call for an implementation of experimental approaches in order to satisfy hazard data requirements for up to 30,000 existing chemicals [EINECS -European Inventory of Existing Chemical Substances (16) ]. This will result in a great increase in animal use for the safety assessment of chemicals and cosmetic ingredients and of the costs for performing timeconsuming in vivo bioassays, in fact each in vivo assay requiring 100-200 animals with a time to result of two to four years. Obviously, this represents a serious bottleneck for the backlog testing of chemicals. Therefore the availability of more feasible and validated test methods in the field of chemical carcinogenesis becomes matter of urgency. In this regard, cell transformation assays, not calling for the use of animals and providing results in 4-6 weeks, offer an attractive alternative. Indeed, the European Centre for the Validation of Alternative Methods (ECVAM) has recently taken into account the validation of the two cell transformation assays Baib/c3T3 and Syrian Hamster Embryo (SHE).
The Balb/c 3T3 can be used as a one-or twostage assay using the formation of transformed foci as the endpoint for establishing the carcinogenic potential of chemicals or their tumour promoting activity (17) . Differently from the SHE assay that uses primary cells, the Balb/c3T3 assay is based on the use of a cloned immortalized mouse fibroblast cell line, not calling for any animal sacrifice and allowing for setting up homogenous and standardised working cell banks. However, statistical analysis of the experimental data to assess the foci formation in exposed vs unexposed (control) cells is not well established and might represent a problem in the validation process of the assay. Indeed, test performance parameters such as concordance, sensitivity and specificity that define the predictive capacity of the assay, are highly dependent on data analysis. Generally, Student's t-test is applied to assess test data. However, to our experience this can lead to a number of false negative conclusions.
The objective of the present work is to improve the use of the information in the data generated by the Balb/c 3T3 cell transformation assay by applying two statistical approaches (t-test approach and Fisher's exact test). To the best of our knowledge the Fisher test has not been routinely applied to the Balb/c3T3 transformation assay, not excluding, however, that some industry laboratories may have used it. For the purpose of verifying the correctness of the approach adopted we carried out a series of Balb/c3T3 cell transformation studies on a number of metal compounds classified as carcinogenic (NaAsO z ' CdCl z , cisPt), as suspected carcinogenic «C6Hs)4AsCI, CH)HgCI), or as compounds without evidence of carcinogenic properties in humans «NH 4)ltCI6 , NaVO)) as well as a non-carcinogen (AgNO)).
MATERIALS AND METHODS

Metal compounds tested
The metal compounds tested were selected according to their known carcinogenic potential in humans and! or in vitro systems, as classified by the International Agency for the Research on Cancer (lARC) Monographs Programme On the Evaluation of Carcinogenic Risks to Humans, the US Environmental Protection Agency's National Toxicology Program (NTP), and in relation with independent studies in in vitro systems (18) (19) (20) (21) (22) (23) . Cis-diamminoplatinum(II)dichloride [(NH 3)ltCI 2 , CAS N°15663-27-1, hereafter named cis-Pt], methylmercury chloride (CH 3HgCI, CAS N°115-09-3, hereafter named MeHg), ammonium hexachloroplatinate [(NH 4)ltCI6, CAS N°1332-76-9], tetraphenylarsonium chloride [(C6H)4AsCI'HP, CAS W507- and sodium arsenite (NaAs0 2 , CAS W7784- were supplied by Sigma-Aldrich, Milan, Italy; silver nitrate (AgN0 3 , CAS W7761-88-8), cadmium chloride (CdCI 2 , CAS WI 0 I08-64-2) and sodium metavanadate (NaY0 3 , CAS W13718-26-8) from Alfa Aesar, Germany. All metal compounds were analysed for elemental impurities by Inductively Coupled Plasma-Mass Spectrometry (lCP-MS), Graphite Furnace-Atomic Absorption Spectrometry (GF-AAS) or Neutron Activation Analysis (NAA). The results of the analysis (not reported in the present work) indicate that the metal compounds tested have a degree of purity suitable to avoid possible artefacts due to the presence of inorganic impurities, as seen in former studies (24) .
Cell culture and media
Cells used in this study were Balb/c3T3 mouse fibroblasts stemming from the clone A31-1-1. They were purchased from the Istituto Zooprofilattico Sperimentale di Brescia, Italy. All working cultures were supplied with mycoplasma-free and source certification. Experimental cultures were prepared from deep-frozen stock vials 37°C in a humidified atmosphere in a cell incubator with 5% CO 2 regulation for 24 hours (HERAEUS, Germany). The range of passage levels for exposure treatments never exceeded passage W 95 (25) .
Concurrent cytotoxicity and morphological transformation assay
The Balb/c3T3 assay, which involves two separate steps, has been carried out by determining the cytotoxicity in terms of the Colony Forming Efficiency, CFE, i.e. the ratio between the mean of colonies per treatment and the mean of colonies in the control expressed as percentage, and neoplastic morphological transformation (formation of type III foci) as previously described (20) .
Cytotoxicity
Briefly, cells were seeded at the density of 200 cells/dish in 4 mL DMEM complete medium (60x 15 nun petri dish, 6 dishes per determination). After 24 h the medium was changed and 4 mL of fresh medium containing the metal compound to be tested were added to obtain the appropriate final metal concentration (Table I) . After 72 h of exposure, the dishes were fed with the complete medium, and 7 days later the cells were fixed with 10% of formaldehyde solution in PBS, stained with 10% Giemsa solution in ultrapure water and colonies were scored for CFE.
Morphological transformation assay
Cells were seeded at the density of I0 4 cells/dish in 4 mL DMEM complete medium. After 24 h the medium in each dish (18-20 dishes per test concentrations) was changed to one containing the selected dose of metal compound to which cells were exposed for 72 h. After treatment, the cultures were maintained for 5 weeks, the culture media being renewed twice a week, then fixed and stained as reported above. Control cultures were treated with the corresponding amount of bidistilled water only. Type III foci were scored for morphological transformation as previously described (20, 23, 26) . Transformation results were expressed as the probability of a neoplastic event per surviving cells (II). The amount of surviving cell fraction is calculated as the percentage of cells remaining plated after seeding and surviving after toxicant treatment at the given dose. The transformation frequency (Tf) was expressed using the following formula: Tf = total number of type III foci per treatment / 
Statistical data analysis
The morphological transformation data were analysed by two procedures: Student's t-test (27) , and Fisher's exact test (28) . In the widely used t-test approach (see Table IV ) the numbers of foci per dish are counted for every control and concentration of treatment. These results are then processed in three steps ( variances. III. Treatment-control comparison: application of a twosided t-test, assuming either equality or inequality of the variances (depending on the result in step II), to compare every treatment with the control (significance level of 5% for each comparison). In the first step one focus is added throughout, as the logarithm of 0, i.e. dishes without any foci, is not defined. The t-tests were calculated with the software package S-Plus 6.2 (© Insightful, Seattle, WA). The approach and implicit assumptions are discussed below. The analysis of the data with Fisher's exact test is based on the transformation frequency, i.e. the ratio of the total number of foci in al1 dishes and the number ofsurviving cel1s after exposure. This frequency is calculated for each control and treatment and can be interpreted as the probability that a cel1 forms a focus. Fisher's exact test is applied to compare each treatment against the negative control. Since there are usual1y no foci in the negative control the test is one-sided by definition. In order to allow optimal comparison with the t-test, the same significance level of 5% was applied. Fisher's exact test was calculated by an online-tool provided on http: //www.matforsk.no/ola/fisher.htm.
RESULTS
The carcinogenic potential of methylmercury chloride is not well established. According to the Registry of Toxic Effects of Chemical Substances (RTECS) criteria the chemical is carcinogenic. The US Environmental Protection Agency (US-EPA) reports inadequate data in humans and limited evidence ofcarcinogenicity in animals, and therefore classifies methylmercuric chloride as "possible human carcinogen" (Classification: C), (30) (31) (32) (33) (34) . As for the International Agency for Research on Cancer (IARC), there is sufficient experimental evidence in animals for the carcinogenicity of methylmercury chloride, and methylmercury compounds are possibly carcinogenic to humans (Group 2B), (31) (32) (33) (34) . To our knowledge, no attempts to study methylmercury chloride in cell transformation assays have been reported to date; we selected this compound for the Balb/c3T3 cell transformation assay. Table I summarises the results concerning the morphological transformation assay after 72 h of exposure of Balb/c3T3 cells to selected concentrations of MeHg (0.1 and 3~M, three independent experiments) in comparison to positive control (0.7~M cis-Pt, C+) and unexposed cells (C). This information allows assessing the significance of the type III foci formation in exposed cells vs control by the t-test approach, which is calculated with the information of the last column only, and Fisher's exact test, which incorporates the surviving cells after exposure and the total number of type III foci per treatment.
The results show a rather high degree of inter-experimental variability, which can be partly explained by a number of factors, such as variations in serum quality (35) , cell line passage numbers, lot-to-Iot variation of the plastic ware, storage conditions of source material, etc. All these parameters would need strict standardization for assay validation. Table II summarises the results of the comparison of statistical analysis of the data of Table I , determined by the two statistical approaches where bold-typed p-values are significant to the level of 5%. Because there was no focus-formation and hence no variation in all three negative controls (C-), the F-test, the second step in the t-test approach, results by definition in heterogeneity of variances. Nevertheless, the p-values for both variance scenarios were calculated. These were very similar while the values of the more conservative t-test for unequal variances were, again by definition, larger. In all cases Fisher's exact test resulted in p-values which were smaller than the respective t-test values. Thus, mainly by taking the number of surviving cells into account, Fisher's test is more sensitive, most strikingly for 3 flM MeHg, in experiments 2 and 3 with five and two foci, respectively. Table III shows the results of the morphological transformation assay after 72 h of exposure of Balb/c3T3 cells to selected concentrations of AgN0 3 , NaAsO z' cisPt, caci; (C6Hs)4AsCI, MeHg, (NH 4)zPtCI6, NaV0 3 in comparison to unexposed cells (C-). The compounds were grouped by their carcinogenic properties derived from IARC Monographs Programme On the Evaluation of Carcinogenic Risks to Humans and from the US Environmental Protection Agency's National Toxicology Program (NTP) data. Again, Fisher's exact test is more sensitive than the t-test approach, most obviously for NaAsO z' a known carcinogen, for which the t-test did not reveal a significant difference in the number of foci compared to the negative control.
DISCUSSION
Cell transformation assays are attractive alternative tools for studying potentially carcinogenic compounds. The first assay of this type was developed almost forty years ago by Berwald and Sachs (36) . However, no in vitro cell transformation assay has yet reached regulatory status, probably due to the lack of concerted validation efforts. The Balb/c3T3 neoplastic transformation assay (17) is a potential candidate for such regulatory validation, and therefore clearly defined standard operating procedures need to be defined. The results of this study exhibit a rather important level of inter-experimental variability (Table I) . Such fluctuations may be attributable to variations, as mentioned above. It can be hoped that a thorough standardization of all source materials, cells and procedures will reduce the experimental variability.
In this context, it should also be noted that the in vivo rodent carcinogenicity bioassay exhibits at least similar ranges of inter-experimental variability (37) . Using the data of the Carcinogenic Potency Database (38) from the University of California, Berkeley, which includes results on 1451 chemicals tested in the rodent bioassay, Gaylor and Chen (39) showed substantial variability of the assay, with differences generally within a factor of 100.
The main problem features of the assay that need to be resolved before a process of assay validation may be sought consist in (I) the fact that many different clones of the Balb/c 3T3 cell line have been in use, and (2) no adequate method to express and analyze the data output have been developed. Due to biological relevance of induced type III foci, a clone that generates the lowest background noise without losing sensitivity should be used. For this reason we propose the clone A31-1-1 because this strain of Balb/c3T3 cells does not generate transformed foci in the absence of treatment, i.e. in control plates. Regarding data analysis, several working group reports have helped in laying down recommendations and guidancelines for the experimental steps of the assay (12-13, 35, 40-41) , but lack thorough assessment to identify sound and appropriate approaches for statistical data analysis. It seems that the Students' t-test that uses the plate as the sampling unit is the most commonly used statistical approach (Table IV) . However, the application of the t-test has often been a critical issue, especially in situations where low transformation frequencies are observed. Indeed, the t-test procedure is highly questionable (42) and efforts to improve the statistical approach have been described (43) .
Our study demonstrates that the analysis procedure of Balb/c3T3 cell transformation data is enhanced by applying Fisher's exact test, where the whole cell fraction per treatment group becomes the sampling unit and transformation frequency is expressed on a surviving cell basis, as suggested by a number of authorities and working groups (Table  IV) . As the formation of a focus is a very rare event, where generally no type III foci are spontaneously formed in negative controls, approaching the data analysis by a t-test, which assumes normality of data, is not appropriate. The number of foci per dish, which could at most be considered an ordinal measurement, has, even if transformed, a highly skewed and thus non-normal distribution. Parameters like the mean and the variance do not describe the distribution properly. In addition, the t-test does not incorporate the information from the cytotoxicity test implicitly assuming that the numbers of surviving cells of the negative control and of the treatments are equal. In contrast, in the Fisher's exact test the number of the surviving cells builds the base for calculating the probability for a cell to form a focus. Indeed, the transforming event does only occur in surviving cells and not in apoptotic or necrotic cells. Thus transformation frequency only makes sense for surviving cells that will eventually lead to the transformed phenotype. The only assumption made is that the CFE from the cytotoxicity assay holds true for the cell transformation assay. This aspect, which will be investigated further, still leaves some room for optimising the assay design and thus data analysis, but also the general testing approach can be optimised. In order to obtain an optimal comparison of the two approaches, we adopted the significance level of 5% usually employed for the t-test. However, we recommend taking the multiple testing scenario into account, e.g. by the Bonferroni procedure, i.e. testing to a significance level of 5% divided by the number of comparisons/concentrations. If a sufficient number of concentrations is tested, the Cochrane-Armitage test might offer an additional method of analysing the data.
Several metal compounds were assayed in the Balb/c3T3 morphological cell transformation system. The carcinogenicity classification according to IARC and RTECS concerning the metal compounds tested in this work is summarised in Table V together with literature and our in vitro data. The conclusions of the present work based on Fisher exact test are in good agreement with IARC and RTECSINTP classifications as well as with in vitro data from literature. In particular, the data confirm i) the carcinogenic potential ofNaAs0 2, CdCl 2 and cis-Pt established both in humans and in vitro models, ii) the transforming activity ofNaVOl in in vitro models as well as iii) the suspected human carcinogenicity of MeHg and (C6Hs)4AsCI. Regarding the two compounds AgNO) and (NH4)2PtCI6' for which no data on their carcinogenic potential exist, our results suggest (NH 4)ltCI6 as carcinogen compound in vitro.
